Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07316478 · ClinicalTrials.gov registry record · NA

Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07316478 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 50 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07316478, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine whether a new stress management and mindfulness program can improve quality of life in individuals with sickle cell disease. The program is based on a number of empirically supported treatments including techniques from cognitive-behavioral therapy like overcoming motivational barriers to self-care, learning to see things as accurately as possible, practicing assertive communication, relaxation exercises like deep slow breathing, mindfulness meditation, and other stress management strategies.

Conditions Studied

Interventions

  • BEHAVIORAL Stress Management and Mindfulness Intervention for Patients with Sickle Cell Disease

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-01-15
Est. Completion 2026-12-30
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT07316478

The ClinicalTrials.gov registry entry for NCT07316478 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (83% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Stress Management and Mindfulness Intervention for Patients with Sickle Cell Disease is the first listed.

NCT07316478 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07316478 about?

NCT07316478 is a clinical study titled "Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease". The purpose of this research is to determine whether a new stress management and mindfulness program can improve quality of life in individuals with sickle cell disease. The program is based on a number of empirically supported treatments including techniques from cognitive-behavioral therapy like o...

What is the current status of trial NCT07316478?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-15. Estimated completion is 2026-12-30.

What conditions does trial NCT07316478 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT07316478?

The interventions under investigation include: Stress Management and Mindfulness Intervention for Patients with Sickle Cell Disease (BEHAVIORAL).

Who is sponsoring clinical trial NCT07316478?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07316478 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.